Can we achieve true drug-free remission in patients with RA?
- 1 February 2010
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 6 (2) , 68-70
Abstract
Since the introduction of new biologic agents and intensive treatment strategies that aim to tightly control disease activity, clinical remission has become a realistic target in patients with rheumatoid arthritis. Once patients are in continuous remission, however, is it realistic to consider withdrawing DMARD therapy?Keywords
This publication has 10 references indexed in Scilit:
- Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-upScandinavian Journal of Rheumatology, 2010
- Treatment of rheumatoid arthritis: state of the art 2009Nature Reviews Rheumatology, 2009
- Prevalence of and predictive factors for sustained disease‐modifying antirheumatic drug–free remission in rheumatoid arthritis: Results from two large early arthritis cohortsArthritis & Rheumatism, 2009
- Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-upScandinavian Journal of Rheumatology, 2009
- Optimizing treatment with biologics.2007
- Tight control in the treatment of rheumatoid arthritis: efficacy and feasibilityAnnals of the Rheumatic Diseases, 2007
- EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2007
- Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritisThe Lancet, 1996
- Preliminary criteria for clinical remission in rheumatoid arthritisArthritis & Rheumatism, 1981